285 related articles for article (PubMed ID: 12592383)
21. IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element.
Meraro D; Gleit-Kielmanowicz M; Hauser H; Levi BZ
J Immunol; 2002 Jun; 168(12):6224-31. PubMed ID: 12055236
[TBL] [Abstract][Full Text] [Related]
22. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
23. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.
Brass AL; Kehrli E; Eisenbeis CF; Storb U; Singh H
Genes Dev; 1996 Sep; 10(18):2335-47. PubMed ID: 8824592
[TBL] [Abstract][Full Text] [Related]
24. Multiple Ets factors and interferon regulatory factor-4 modulate CD68 expression in a cell type-specific manner.
O'Reilly D; Quinn CM; El-Shanawany T; Gordon S; Greaves DR
J Biol Chem; 2003 Jun; 278(24):21909-19. PubMed ID: 12676954
[TBL] [Abstract][Full Text] [Related]
25. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
[TBL] [Abstract][Full Text] [Related]
26. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
27. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
[TBL] [Abstract][Full Text] [Related]
28. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
29. The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.
Schneider EM; Torlakovic E; Stühler A; Diehl V; Tesch H; Giebel B
J Pathol; 2004 Dec; 204(5):538-45. PubMed ID: 15538755
[TBL] [Abstract][Full Text] [Related]
30. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
31. Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis.
Carbone A; Gloghini A; Cozzi MR; Capello D; Steffan A; Monini P; De Marco L; Gaidano G
Br J Haematol; 2000 Oct; 111(1):247-57. PubMed ID: 11091208
[TBL] [Abstract][Full Text] [Related]
32. Human herpesvirus-6 (HHV-6) in Hodgkin's disease: cellular expression of viral antigens as compared to oncogenes met and fes, tumor suppressor gene product p53, and interleukins 2 and 6.
Krueger GR; Guenther A; Knuefermann R; Kluppelberg U; Luka J; Pearson GR; Ablashi DV; Juecker M; Tesch H
In Vivo; 1994; 8(4):501-16. PubMed ID: 7893977
[TBL] [Abstract][Full Text] [Related]
33. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells.
Bargou RC; Leng C; Krappmann D; Emmerich F; Mapara MY; Bommert K; Royer HD; Scheidereit C; Dörken B
Blood; 1996 May; 87(10):4340-7. PubMed ID: 8639794
[TBL] [Abstract][Full Text] [Related]
34. Loss of functional pRB is not a ubiquitous feature of B-cell malignancies.
Sinclair AJ; Frost V
Br J Cancer; 1999 May; 80(5-6):670-5. PubMed ID: 10360642
[TBL] [Abstract][Full Text] [Related]
35. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
McCune RC; Syrbu SI; Vasef MA
Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.
Carbone A; Cilia AM; Gloghini A; Capello D; Todesco M; Quattrone S; Volpe R; Gaidano G
Br J Haematol; 1998 Sep; 102(4):1081-9. PubMed ID: 9734661
[TBL] [Abstract][Full Text] [Related]
37. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
Linderson Y; French NS; Neurath MF; Pettersson S
Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
[TBL] [Abstract][Full Text] [Related]
38. Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells.
Nagy M; Chapuis B; Matthes T
Br J Haematol; 2002 Feb; 116(2):429-35. PubMed ID: 11841448
[TBL] [Abstract][Full Text] [Related]
39. Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.
Goto H; Kariya R; Kudo E; Okuno Y; Ueda K; Katano H; Okada S
Oncogene; 2017 Sep; 36(37):5252-5262. PubMed ID: 28481873
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]